DETROIT, March 12, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to report on the Fifteenth Meeting of the ISO/TC 229 Nanotechnologies Conference held last week in Queretaro City, Mexico.
Nano Labs was proud to sponsor two important events in the field of international regulations of nanotechnology, in the colonial City of Queretaro, in Central Mexico. The first was a joint Organization for Economic Co-operation and Development (OECD)/ International Organization for Standardization (ISO) Expert Meeting on Physical-Chemical Properties of Manufactured Nanomaterials and Test Guidelines, and the second the 15th Meeting of ISO/TC 229 Nanotechnologies by the ISO Secretariat.
"Both events are among the most important events in terms of international regulatory policies and, for the very first time, were opened to the participation of private companies, among which Nano Labs had a distinguished presence. One of the major issues of the ISO conference is to establish a global ISO standard and regulate the safety issues related to the production and uses of nano particles in the manufacturing process on a global scale," stated Dr. Victor Castano, Chief Innovations Officer of Nano Labs, who attended the conference. "The presence of Nano Labs was significant for the development of the events, not only because of the sponsorship, but also due to the fruitful networking among industry, academia and government agencies that took place during these days."
"The ISO organization promotes worldwide proprietary, industrial, and commercial standard, this was an excellent opportunity for Nano Labs to take center stage at an International event," stated Bernardo Chavarria, President of Nano Labs Corp.
About the ISO/TC 229 Nanotechnologies Conference
The Fifteenth Meeting of the ISO/TC 229 conference is an invitation-only meeting based on formal invitations issued by the Dirección General de Normas of the Ministry of Economy of Mexico, as the official Mexican representative to ISO, and organized by the Instituto Mexicano de Normalización y Certificación, A. C., (http://www.imnc.org.mx/), as the standardization organization in Mexico attending the works on voluntary standards for nanotechnologies in Mexico. Over 200 nanotechnology delegates, who are industry and government experts from 34 countries around the world, attended the meetings, with the objective being to produce ISO Global standards on nanotechnologies. Nano Labs was a key sponsor for the event.
About Nano Labs
Nano Labs Corp. (CTLE) is a nanotechnology company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us.
The Nano Labs Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16293
Forward looking statements
This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.